UPDATE : Thursday, October 18, 2018
상단여백
Roche Diagnostics donates ₩15 mil. to prevent child abuse
Roche Diagnostics Korea CEO Richard Yiu (left) and Korea Association for Pr...
by Marian Chu  |  2018-08-24 12:10
라인
Hana Pharm performs P3 tests for new anesthetic agent
Hana Pharm said Thursday that it is conducting phase 3 trials for a new sed...
by Marian Chu  |  2018-08-23 17:31
라인
Boryung launches rapid influenza diagnostic kit
Flu Fast Boryung BioPharm said Thursday it launched its rapid diagnostic ...
by Marian Chu  |  2018-08-23 16:46
라인
Ildong, Sandoz to ally in Asia-Pacific
Ildong Pharmaceutical said Thursday that it would enter a strategic allianc...
by Marian Chu  |  2018-08-23 15:11
라인
Myungmoon Pharm’s valsartan additionally suspended
The government said it has completed testing all valsartan-using hypertensi...
by Lee Hye-seon  |  2018-08-23 15:10
라인
3 multinationals refuse to take pharma group’s anti-corruption system
GSK Korea, Janssen Korea and Astellas Pharma Korea refused to adopt ISO 370...
by Nam Doo-hyun  |  2018-08-23 12:01
라인
Dong-A ST, Takara Bio signs licensing agreement for oncolytic virus therapy
Dong-A ST said Thursday it signed a development and sales licensing agreeme...
by Marian Chu  |  2018-08-23 11:49
라인
Bridge Biotherapeutics presents preclinical trial results on ATX inhibitor
Bridge Biotherapeutics, also known as BridgeBio, said Thursday it presented...
by Marian Chu  |  2018-08-23 10:31
라인
5 Korean biopharmaceuticals most active in P3 trials in 5 years
More and more Korean pharmaceuticals are jumping into developing new drugs,...
by Marian Chu  |  2018-08-23 10:31
라인
Foreign CEOs to lead Korean units of Novartis, Galderma
Novartis Korea and Galderma Korea will have new foreign CEOs next month.Nov...
by Nam Doo-hyun  |  2018-08-22 13:56
라인
Boehringer Ingelheim to present sub-analyses on Pradaxa at ESC Congress 2018
Boehringer Ingelheim Korea said Wednesday it would present nine sub-analyse...
by Marian Chu  |  2018-08-22 12:31
라인
Lixiana faces patent challenge in substance, composition
Daiichi Sankyo’s anticoagulant treatment Lixiana (ingredient: edoxaban) has...
by Lee Hye-seon  |  2018-08-22 11:16
라인
Shire Korea gets approval for short bowel syndrome treatment
Rare disease specialty biopharmaceutical firm Shire Korea said Wednesday it...
by Marian Chu  |  2018-08-22 11:15
라인
Pharma group will no longer provide souvenirs to medical workers
The Korea Research-based Pharma Industry Association (KRPIA) announced Tues...
by Lee Han-soo  |  2018-08-21 18:11
라인
Handok releases special medical food for Alzheimer’s
Handok said Tuesday that it has launched Souvenaid, a special medical food ...
by Lee Han-soo  |  2018-08-21 15:57
라인
Daiichi Sankyo publishes 1st RWD on Lixiana on Koreans
Daiichi Sankyo Korea published the first real-world data on Koreans for its...
by Marian Chu  |  2018-08-21 15:57
라인
Sanofi Pasteur, KSOC vaccinate S. Korean national squad for 2018 Asian Games
Korean athletes participating in the 2018 Asian Games in Jakarta and Palemb...
by Marian Chu  |  2018-08-21 11:50
라인
Hanmi unveil P3 clinical trial results for asthma-rhinitis combination drug
Hanmi Pharmaceutical said that it has presented the phase 3 clinical trial ...
by Lee Han-soo  |  2018-08-20 16:54
라인
Canada approves Daewoong’s BTX
Daewoong Pharmaceutical said Monday that it has received sales approval for...
by Lee Han-soo  |  2018-08-20 14:39
라인
GC Cell gets FDA orphan drug designation for Immuncell-LC
GC Cell said Friday that it got an orphan drug designation from the U.S. Fo...
by Marian Chu  |  2018-08-20 12:09
여백
여백
여백
Back to Top